IRB (Institutional Review Board) approval and informed consent process

IRB approval
Mention whether the study has been approved by an IRB.
Informed consent
Describe the informed consent process. Where were the participants told the length of time of the survey, which data were stored and where and for how long, who the investigator was, and the purpose of the study?
Data protection If any personal information was collected or stored, describe what mechanisms were used to protect unauthorized access. 
Development and pre-testing
Number of Items
What was the number of questionnaire items per page? The number of items is an important factor for the completion rate.
Number of screens (pages)
Over how many pages was the questionnaire distributed? The number of items is an important factor for the completion rate.
Completeness check
It is technically possible to do consistency or completeness checks before the questionnaire is submitted. Was this done, and if â yesâ , how (usually JAVAScript)? An alternative is to check for completeness after the questionnaire has been submitted (and highlight mandatory items). If this has been done, it should be reported. All items should provide a nonresponse option such as â not applicableâ or â rather not sayâ , and selection of one response option should be enforced.
Review step
State whether respondents were able to review and change their answers (eg, through a Back button or a Review step which displays a summary of the responses and asks the respondents if they are correct).
Response rates
Unique 
Preventing multiple entries from the same individual
Cookies used Indicate whether cookies were used to assign a unique user identifier to each client computer. If so, mention the page on which the cookie was set and read, and how long the cookie was valid. Were duplicate entries avoided by preventing users access to the survey twice; or were duplicate database entries having the same user ID eliminated before analysis? In the latter case, which entries were kept for analysis (eg, the first entry or the most recent)?
IP check Indicate whether the IP address of the client computer was used to identify potential duplicate entries from the same user. If so, mention the period of time for which no two entries from the same IP address were allowed (eg, 24 hours). Were duplicate entries avoided by preventing users with the same IP address access to the survey twice; or were duplicate database entries having the same IP address within a given period of time eliminated before analysis? If the latter, which entries were kept for analysis (eg, the first entry or the most recent)?
Log file analysis
Indicate whether other techniques to analyze the log file for identification of multiple entries were used. If so, please describe.
Registration
In â closedâ (non-open) surveys, users need to login first and it is easier to prevent duplicate entries from the same user. Describe how this was done. For example, was the survey never displayed a second time once the user had filled it in, or was the username stored together with the survey results and later eliminated? If the latter, which entries were kept for analysis (eg, the first entry or the most recent)?
Analysis
Handling of incomplete questionnaires
Were only completed questionnaires analyzed? Were questionnaires which terminated early (where, for example, users did not go through all questionnaire pages) also analyzed?
Questionnaires submitted with an atypical timestamp Some investigators may measure the time people needed to fill in a questionnaire and exclude questionnaires that were submitted too soon. Specify the timeframe that was used as a cut-off point, and describe how this point was determined.
Statistical correction
Indicate whether any methods such as weighting of items or propensity scores have been used to adjust for the nonrepresentative sample; if so, please describe the methods.
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